Total Funding
26
65
Total FundingSeed raised
Growth Score 26 in past quarter
-44 pts
Heat Score 65 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
127197
Key Proteo is a developer of a novel peptide screening for newborn babies.
About the Company
Key Proteo is a developer of a novel peptide screening for newborn babies. The company aims to improve and expand the current newborn screening programs and subsequently provide early intervention for genetic diseases before they are clinically manifested.
It specializes in multiplex analysis for any extremely low-abundance proteins from a few
drops of blood (DBS) using surrogate peptide markers by mass spectrometry. With this new technology, Key Proteo targets new or existing genetic conditions to change their clinical course and ensure a better quality of life for its patients.